10 Healthcare Stocks to Buy According to Peter S. Park’s Park West Asset Management
In this article, we discuss the 10 healthcare stocks to buy according to Peter S. Park's Park West Asset Management based on Q2 holdings of the fund.
Viking Therapeutics Inc. (VKTX)
Get Email AlertsHedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Park West Asset Management Peter S. Park | 1,668,587 | $10,479 | 0.24% | |
| 2. | Two Sigma Advisors John Overdeck And David Siegel | 938,828 | $5,896 | -5% | 0.01% |
| 3. | Sio Capital Michael Castor | 660,813 | $4,150 | +7% | 1.32% |
| 4. | Ikarian Capital Neil Shahrestani | 500,642 | $3,144 | -5% | 0.22% |
| 5. | DAFNA Capital Management Nathan Fischel | 447,400 | $2,810 | 0.74% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.69 | 20,000 | Director | 66,250 | 2021-06-10 | Filing | |
| $9.82 | 9,500 | Director | 9,500 | 2018-05-31 | Filing | |
| $5.16 | 30,000 | Director | 30,000 | 2018-05-29 | Filing | |
| $5.21 | 8,000 | Director | 8,000 | 2018-05-29 | Filing | |
| $5.22 | 47,965 | Director | 47,965 | 2018-05-29 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $8.11 | 148,700 | Large Shareholder | 5,819,383 | 2020-08-26 | Filing | |
| $8.11 | 94,488 | Large Shareholder | 5,819,383 | 2020-08-26 | Filing | |
| $8.02 | 70,000 | Large Shareholder | 5,968,083 | 2020-08-25 | Filing | |
| $7.35 | 13,000 | Director | 26,250 | 2020-06-30 | Filing | |
| $19.15 | 262,881 | Large Shareholder | 6,038,083 | 2018-09-25 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 18,679 | $86 | 0.01% | |
| 2. | 14,800 | $68 | 0% | |
| 3. | 7,500 | $35 | 0% | |
| 4. | 1,730 | $8 | 0% | |
| 5. | 354 | $1 | 0% |
News See All
10 Best Biotech Stocks Under $10
In this article, we discuss the 10 best biotech stocks under $10.
5 Best Growth Stocks Under $10
Aurora Cannabis Inc. (NASDAQ: ACB) is a Canadian company that makes and sells cannabis products. It is ranked fifth on our list of 10 best growth stocks under $10.
Bumbershoot Holdings: “Viking Therapeutics (VKTX) Struggled Right Off the Bat”
Bumbershoot Holdings LP, an investment management firm, published its fourth quarter 2020 investor letter – a copy of which can be downloaded here. Bumbershoot Holdings L.P.
Is VKTX A Good Stock To Buy Now?
Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfolios.
Did Hedge Funds Make The Right Call On Viking Therapeutics, Inc. (VKTX) ?
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming).
Should You Buy Viking Therapeutics, Inc. (VKTX)?
We at Insider Monkey have gone over 821 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio positions as of March...
Is Viking Therapeutics, Inc. (VKTX) A Good Stock To Buy?
"The global economic environment is very favorable for investors. Economies are generally strong, but not too strong. Employment levels are among the strongest for many decades.
Were Hedge Funds Right About Souring On Viking Therapeutics, Inc. (VKTX)?
Is Viking Therapeutics, Inc.
Here’s What Hedge Funds Think About Viking Therapeutics, Inc. (VKTX)
Is Viking Therapeutics, Inc.
Billionaire Hedge Funds
